Over 10 years experience of Traceability Solutions
By Pharmatrax Author
Category: Technoloy
No Comments Scientists have developed a technique that could significantly reduce the time to discover potential new antibody-based drugs to treat disease. Antibodies are produced by the…
By Pharmatrax Author
Category: Technoloy
No Comments The SARS-CoV-2 viral genome encodes for 29 proteins—many of which could serve as potential targets for anti-viral drugs. In order to rapidly discover lead compounds…
By Pharmatrax Author
Category: Technoloy
No Comments Judging from trends in other countries, the next few weeks will be critical to ramp up production of essential testing kits and personal protection equipment…
By Pharmatrax Author
Category: Technoloy
No Comments It will likely take at least a year for a Covid-19 vaccine to be approved and made available to patients; something which Pharma Tech readers…
By Pharmatrax Author
Category: Technoloy
No Comments Some pharmaceutical and biotech stocks have emerged as the most eye-catching hot stocks in South Korea amid hope for the discovery of potential cures or…
By Pharmatrax Author
Category: News
No Comments Eurofins Discovery’s mission is to support Pharmaceutical and Biotech companies in their efforts to accelerate drug discovery research and development. The COVID-19 crisis is putting…
By Pharmatrax Author
Category: News
No Comments Novartis, like many generic drugmakers, was forced to pull copies of generic Zantac off shelves late last year after a carcinogen scare shocked the industry. Now, it’s…
By Pharmatrax Author
Category: Technoloy
No Comments Scientists have developed a technique that could significantly reduce the time of discovering potential new antibody-based drugs to treat disease. Antibodies are produced by the…
By Pharmatrax Author
Category: Technoloy
No Comments The two companies are combining their technologies to speed the process of bringing to market treatments for Dengue fever and other diseases. PolarisQB (based in…
By Pharmatrax Author
Category: News
No Comments BenevolentAI, a startup which has raised $292 million to apply AI to create drugs faster, today says it has uncovered an already approved drug as…